Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Article in English | MEDLINE | ID: mdl-33724264

ABSTRACT

BACKGROUND: Primary preventive implantation of implantable defibrillator (ICD) is according to current guidelines indicated in patients with heart failure NYHA (New York Heart Association) class II/III and LVEF <35%. Thanks to advances in heart failure pharmacotherapy, a decrease in mortality could render a benefit of ICD insufficient to justify its implantation in some patients. METHODS: Study design: multicenter, prospective, randomized, controlled trial evaluating the benefit of implantation of Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in non-ischemic patients with reduced left ventricle ejection fraction (LVEF) and optimal pharmacotherapy without significant mid-wall myocardial fibrosis detected by cardiac magnetic resonance (CMR). The primary end-point: Re-hospitalization for heart failure, ventricular tachycardia, major adverse cardiac events (MACE). The secondary end-points: Sudden cardiac death, cardiovascular death, resuscitated cardiac arrest or sustained ventricular tachycardia, device-related complications, and change in quality of life. Course of the study: After a pharmacotherapy is optimized and significant mid-wall myocardial fibrosis excluded, patients will be randomized 1:1 to CRT-P or CRT-D implantation. DISCUSSION: If our hypothesis is confirmed, this could provide evidence for the management of these patients with a significant impact on common daily praxis and health care expenditures. CLINICALTRIALS: gov, NCT04139460.


Subject(s)
Cardiac Resynchronization Therapy , Cardiomyopathies , Cardiomyopathy, Dilated , Defibrillators, Implantable , Heart Failure , Tachycardia, Ventricular , Cardiomyopathies/therapy , Cardiomyopathy, Dilated/complications , Cardiomyopathy, Dilated/diagnostic imaging , Cardiomyopathy, Dilated/therapy , Contrast Media , Fibrosis , Gadolinium , Humans , Magnetic Resonance Imaging , Prospective Studies , Quality of Life , Tachycardia, Ventricular/therapy , Treatment Outcome
2.
ESC Heart Fail ; 7(3): 1291-1301, 2020 06.
Article in English | MEDLINE | ID: mdl-32243105

ABSTRACT

Hypocalcaemic cardiomyopathy is a rare form of dilated cardiomyopathy. The authors here present two cases in which symptomatic dilated cardiomyopathy was the result of severe hypocalcaemia. First, we report about a 26-year-old woman with primary hypoparathyroidism and then about a 74-year-old man with secondary hypoparathyroidism following a thyroidectomy. In both cases, the left ventricular systolic function improved after calcium supplementation. In the first case, a lack of compliance led to a repeated decrease of both serum calcium level and left ventricular systolic function. The authors also present a comprehensive summary of all cases of hypocalcaemic dilated cardiomyopathy that have been described in literature to date. The mean age of the affected patients was 48.3 years, of which 62% were female patients. The most common causes of hypocalcaemic cardiomyopathy are primary hypoparathyroidism (50%) and post-thyroidectomy hypoparathyroidism (26%). In the post-thyroidectomy subgroup, the median time for the development of hypocalcaemic cardiomyopathy is 10 years (range: 1.5 months to 36 years). Hypocalcaemic cardiomyopathy leads to heart failure with reduced ejection fraction in 87% of patients. Generally, the most common complications of hypoparathyroidism and/or hypocalcaemia are cerebral calcifications, cognitive deficit, and cataracts. Once calcium supplementation is administered, the disease has a good prognosis and, in most individuals, a significant improvement (21%) or even normalization (74%) of the left ventricular systolic function occurs.


Subject(s)
Cardiomyopathy, Dilated , Hypocalcemia , Hypoparathyroidism , Adult , Aged , Calcium , Cardiomyopathy, Dilated/diagnosis , Cardiomyopathy, Dilated/etiology , Female , Humans , Hypocalcemia/diagnosis , Hypocalcemia/etiology , Hypoparathyroidism/complications , Hypoparathyroidism/diagnosis , Male , Middle Aged , Thyroidectomy
3.
Article in English | MEDLINE | ID: mdl-24881588

ABSTRACT

INTRODUCTION: Acute kidney injury (AKI) following surgical myocardial revascularization is associated with high mortality and morbidity. The aim of this study was to evaluate the risk of acute kidney injury in a population of very old patients following different surgical techniques. PATIENTS AND METHODS: A retrospective study of 310 consecutive patients aged 78 to 93 years, mean 80.5±2.2, who underwent surgery at one cardiac surgery centre. Based on the surgical technique used the patients were divided into: Group I. CABG (n=134) - surgical myocardial revascularization using extracorporeal circulation and arterial and venous grafts. Group II. OPCABG (n=55) - surgical revascularization without extracorporeal circulation but using arterial and venous grafts. Group III. NOTOUCH (n=121) - no handling with the ascending aorta was performed at all. RESULTS: A statistically insignificant renoprotective trend was found in patients who underwent surgery without extracorporeal circulation regardless of technique. Comparing groups II and III vs. group I, a significantly poorer renal functioning (median difference in creatinine was 10.0 (32.9) vs 17.5 (35.0), P=0.05) was shown for patients in group I. CONCLUSION: Surgical myocardial revascularization without extracorporeal circulation in very old patients is safe. The results of this study show a renoprotective trend.


Subject(s)
Acute Kidney Injury/epidemiology , Coronary Artery Disease/surgery , Postoperative Complications/epidemiology , Risk Assessment , Acute Kidney Injury/etiology , Age Factors , Aged , Aged, 80 and over , Coronary Artery Bypass/adverse effects , Coronary Artery Bypass, Off-Pump/adverse effects , Czech Republic/epidemiology , Female , Humans , Incidence , Male , Retrospective Studies , Risk Factors
4.
Nutrition ; 26(9): 910-4, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20692603

ABSTRACT

Calciphylaxis is a rare complication of chronic renal failure mostly with poor prognosis. Painful lesions on various skin surface areas are the most prominent feature of this serious disease. Subsequent infection of necrotic skin tissue is associated with the risk of sepsis. Pathophysiology is unclear, but several risk factors are known. The most important risk factor is impaired calcium-phosphate metabolism. Our paper describes two cases of different forms of calciphylaxis in patients with chronic renal failure. In the first case, pamidronate and cinacalcet were used for treatment. In the second described case, calciphylaxis was associated with secondary hyperparathyroidism and immediate subtotal parathyroidectomy was performed. Both patients were successfully treated, using systemic approach as well as dedicated local care for healing of skin wounds.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Calciphylaxis/etiology , Hyperparathyroidism, Secondary/etiology , Kidney Failure, Chronic/complications , Renal Dialysis/adverse effects , Skin Diseases/etiology , Skin/pathology , Aged , Calciphylaxis/drug therapy , Calciphylaxis/pathology , Cinacalcet , Diphosphonates/therapeutic use , Female , Humans , Hyperparathyroidism, Secondary/pathology , Hyperparathyroidism, Secondary/surgery , Kidney Failure, Chronic/pathology , Kidney Failure, Chronic/therapy , Middle Aged , Naphthalenes/therapeutic use , Pamidronate , Parathyroidectomy , Skin Diseases/pathology
5.
ASAIO J ; 56(3): 200-3, 2010.
Article in English | MEDLINE | ID: mdl-20449895

ABSTRACT

The aim of this study was to investigate an association between vascular access blood flow (QVA), cardiac output(CO), and load of left ventricle (LLV) using a simple physical model calculation based on real data, specifically inpatients with high access blood flow arteriovenous fistula(AVF). Vascular access blood flow, CO, and peripheral vascular resistance (PR) were determined by ultrasound dilution technique (HD01; Transonic Systems, Inc., Ithaca, NY). Load of left ventricle was calculated using simplified formula: LLV x PR CO2. This total load was computationally divided into the part spent to run the flow QVA through the AVF (LLVAVF) and that part ensuring the flow (CO-QVA) through the vascular system. The model calculation was first performed in a selected group of 15 patients with high access blood flow (QVA >1,300 ml/min, group 1) and later extended for comparison by another group of 40 unselected patients with access blood flow in lower range (QVA range 200-1,400 ml/min, group 2).Mean LLV in group 1 was 2.10 +/- 0.68 W. LLV(AVF) was 21.8% of total LLV. Mean LLV in group 2 was 1.2 +/- 0.5 W.LLVAVF was 11.1% of total LLV. Our computational results suggest that AVF in typical range of QVA shall not increase heart load significantly.


Subject(s)
Cardiac Output/physiology , Hemodynamics , Renal Dialysis/methods , Adult , Cardiac Catheterization , Drug Administration Routes , Female , Heart Ventricles/physiopathology , Humans , Indicator Dilution Techniques , Male , Middle Aged , Vascular Resistance
6.
Blood Purif ; 26(5): 468-72, 2008.
Article in English | MEDLINE | ID: mdl-18810229

ABSTRACT

AIM: To assess the variability of blood flow (QVA) through a native arteriovenous fistula (AVF) in the long-term and to determine the QVA reduction at which an intervention is appropriate. PATIENTS AND METHODS: The study was performed in a group of 34 chronic hemodialysis patients with no history of a AVF intervention. QVA was measured using the thermodilution method (Blood Thermodilution Monitor, Fresenius). Median follow-up was 41 months and the median number of QVA measurements in each patient was 15. The coefficient of variation (CV) of QVA was calculated for each patient. RESULTS: Mean QVA was 904 +/- 334 ml/min. The mean CV was 23.3 +/- 11.2%. CONCLUSION: QVA may fluctuate during a long-term follow-up period. The detection of QVA decrease by 20-25% could be still within physiological limits. Based on the results we recommend to first repeat the measurement at a shorter interval and to refer the patient to a radiologist only when the decreasing trend is confirmed.


Subject(s)
Arteriovenous Fistula/physiopathology , Blood Flow Velocity , Renal Dialysis , Aged , Arteriovenous Fistula/therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Retrospective Studies
7.
Blood Purif ; 23(1): 36-44, 2005.
Article in English | MEDLINE | ID: mdl-15627735

ABSTRACT

The article discusses the issue of suitable parameters (pressures, recirculation and access flow) to assess hemodialysis vascular access quality (VAQ), available methods to measure those parameters and the setup of the entire VAQ surveillance system (VAQS) in a dialysis facility. Special attention is paid to factors which need some standardization to enable evaluation of VAQ trends in an individual as well as comparison of data from different patients and different dialysis facilities. The discussed procedures are documented with the authors' own measurement results and the results of the VAQS implemented in their unit. Both dynamic and static pressures exhibit insufficient sensitivity in detecting stenoses in native arteriovenous fistulas. Access recirculation is a late finding because with its non-zero value dialysis quality is already compromised. Timely and reliable detection of a deteriorating access condition is enabled by access flow (QVA) only. No standardization is needed in extracorporeal blood flow used in QVA evaluation by ultrasonic dilution. Multiple measurements may increase the reliability of thermodilutional measurements and are a must in optodilutional ones. Timing of the measurement during dialysis should be standardized. Measurement frequency should take into account access type, QVA value and access history. Shortened intervals are needed in the immediate post-intervention period with regard to risk of re-stenosis incidence and strongly nonlinear QVA decreases in such cases. A significant shift-over from surgical interventions to balloon angioplasties is to be expected with the introduction of a VAQS, and appropriate measures must be taken to ensure their quick availability.


Subject(s)
Arteriovenous Shunt, Surgical/standards , Hemodialysis Units, Hospital/standards , Monitoring, Physiologic/methods , Population Surveillance , Quality Assurance, Health Care/methods , Renal Dialysis/instrumentation , Arteriovenous Shunt, Surgical/adverse effects , Humans , Monitoring, Physiologic/standards , Prospective Studies , Renal Dialysis/standards
SELECTION OF CITATIONS
SEARCH DETAIL
...